Several days ago, in my post on “How Common Is BCVI?” I mentioned a paper recognizing the increasing incidence of BCVI in pediatric patients and the very high stroke rate (37%) and death rate (13%). These numbers are very concerning!

Previous work shows that the Memphis and Denver criteria are not very sensitive in adults. This has led many trauma centers to add CT angiography of the neck automatically in patients with a high-energy mechanism. But what about kids? Are these screening criteria any better?

A consortium of children’s hospital trauma centers has a paper currently in press that evaluated both the Memphis and Denver criteria in children under age 15. It was a four-year prospective, observational study of children with head, face, or neck injuries. Although the Memphis criteria were specifically used in the study, data for applying the original and expanded Denver criteria, EAST practice management guideline criteria, Utah score, and McGovern score were also collected. The last two are pediatric-specific criteria.

Any child who met at least one of the Memphis criteria received a CTA or MRA of the head and neck. In addition, all children with head, face, or neck injuries received a follow-up evaluation two weeks after discharge. This was designed to capture any evidence of BCVI in those who did not meet Memphis criteria and hence had no CTA/MRA. Patients who missed this evaluation or had other missing data were excluded from the analysis.

Here are the factoids:

• A total of 2,284 children met the criteria for enrollment; nearly one-third were excluded due to no imaging/follow-up or missing data (!)
• There were 24 BCVI diagnosed (1.6%)
• Diagnostic accuracy of the various screening criteria were:

The Memphis criteria had the highest sensitivity and would have missed the fewest BCVI. The pediatric-specific Utah score had the highest specificity but would have missed more than half of the injuries. The authors recommend refining the Memphis criteria to improve its specificity while maintaining its high sensitivity.

Bottom line: As with adults, we struggle with systematically identifying BCVI. All screening systems leave something to be desired. It’s not practical or prudent to treat children the same as adults and just liberalize the use of CTA. Substituting MRA is not practical because this requires sedation and/or intubation in the younger age groups.

Of interest in this study, the overall incidence was higher (1.6% here vs. less than 0.5% in my previous post). This is probably due to the fact that there was a significant effort to identify criteria for angiography, and follow-up was provided to detect occult injuries.

This paper adds to the previous work I cited describing how important it is to detect this injury. The current research demonstrates that the Memphis criteria are the best we have for pediatric patients at this time. But it clearly shows the need for a better tool. 

But until one is developed, a best practice would be to use the Memphis criteria to screen any pediatric patient with head, neck, or facial trauma due to a high-energy blunt mechanism. Then select CTA or MRA after conferring with your pediatrics and radiology teams.

Reference: Diagnostic accuracy of screening tools for pediatric blunt cerebrovascular injury: An ATOMAC multicenter study. Journal of Trauma, publish ahead of print, DOI: 10.1097/TA.0000000000003888.

In my last post, I reviewed the grading system for blunt carotid and vertebral artery injury (BCVI). Today, we’ll discuss treatment, and in the next post, we will wrap up with pediatric-specific information.

There are basically three modalities at our disposal for managing BCVI: antithrombotic medication (heparin and/or antiplatelet agents), surgery, and endovascular procedures. The choice of therapy is usually based on surgical accessibility and patient safety for anticoagulation. We know that several studies have shown decreased stroke events in heparinized patients. Unfortunately, this is not always possible due to associated injuries. Antiplatelet agents are usually tolerated after acute trauma, especially low-dose aspirin. However, several studies have shown little difference in outcomes in patients receiving heparin vs. aspirin/clopidogrel for BCVI.

So what to do? Here are some broad guidelines:

• Grade I (intimal flap). Heparin or antiplatelet agents should be given. If heparin can be safely administered, it may be preferable in patients needing other surgical procedures since it can be rapidly reversed by stopping the infusion. These lesions generally heal entirely on their own, so a follow-up CT angiogram should be scheduled in 1-2 weeks. Medication can be stopped when the lesion heals.
• Grade II (flap/dissection/hematoma). These injuries are more likely to progress, so heparin is preferred if it can be safely given. Stenting should be considered, especially if the lesion progresses. Long-term anti-platelet medication may be required.
• Grade III (pseudoaneurysm). Initial heparin therapy is preferred unless contraindicated. Stable pseudoaneurysms should be followed with CTA every six months. If the lesion enlarges, surgical repair should be performed in accessible injuries or stenting in inaccessible ones.
• Grade IV (occlusion). Heparin therapy should be initiated unless contraindicated. Patients who do not suffer a catastrophic stroke may do well with follow-up antithrombotic therapy. Endovascular treatment does not appear to be helpful.
• Grade V (transection with extravasation). This lesion is frequently fatal, and the bleeding must be addressed using the best available technique. For lesions that are surgically accessible, the patient should undergo the appropriate vascular procedure. Inaccessible injuries should undergo angiographic treatment and may require embolization to control bleeding without regard for the possibility of stroke.

References:

1. Scott WW, Sharp S, Figueroa SA, et al. Clinical and radiographic outcomes following traumatic Grade 1 and 2 carotid artery injuries: a 10-year retrospective analysis from a Level I trauma center. J Neurosurg 122:1196, 2015.
2. Scott WW, Sharp S, Figueroa SA, et al. Clinical and radiographic outcomes following traumatic Grade 3 and 4 carotid artery injuries: a 10-year retrospective analysis from a Level 1 trauma center. J Neurosurg 122:610, 2015.
3. Scott WW, Sharp S, Figueroa SA, et al. Clinical and radiological outcomes following traumatic Grade 1 and 2 vertebral artery injuries: a 10-year retrospective analysis from a Level 1 trauma center. J Neurosurg 121:450, 2015.
4. Scott WW, Sharp S, Figueroa SA, et al. Clinical and radiological outcomes following traumatic Grade 3 and 4 vertebral artery injuries: a 10-year retrospective analysis from a Level I trauma center. The Parkland Carotid and Vertebral Artery Injury Survey. J Neurosurg 122:1202, 2015.